TELIX PHARMACEUTICALS LIMITED - Charts / Financials

18.8%

$14.95

Market Cap $5.059B

Healthcare Biotechnology

Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on... Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.More

ASX:AFP

Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals (ASX:AFP). With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for stocks in the sector with room to run. Latest:...

REFRESH

Last update - 15.59pm 28/08/2025 (20 minute delay)

Day
Open	$14.75		Day High	$15.87		Day Low	$13.94
Daily Volume	9018266

Bids				Sellers
Number	Price	Volume		Number	Price	Volume
3	$14.95	533		3	$15.00	2224

Directors & Senior Management

Dr. Christian P. Behrenbruch	Group Chief Executive Officer, Managing Director, Executive Director
Mr. Darren Smith	Group Chief Financial Officer
Mr. Raphaeel Ortiz	Chief Executive Officer - Telix International
Mr. Kevin Richardson	Chief Executive Officer - Telix Precision Medicine
Dr. Darren Patti	Group Chief Operating Officer
Dr. Paul Schaffer	Chief Technology Officer
Ms. Lena Moran-Adams	Group General Counsel
Dr. David Cade	Group Chief Medical Officer
Mr. James Stonecypher	Group Chief Development Officer
Mr. Richard Valeix	Group Chief Commercial Officer
Ms. Tiffany P. Olson	Non-Executive Independent Chairman of the Board
Ms. Marie McDonald	Non-Executive Director
Dr. Mark Nelson	Non-Executive Independent Director
Ms. Jann Skinner	Non-Executive Independent Director

Data source: Refinitiv

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $14.95		Change -3.450(18.8%)		Mkt cap ! $5.059B

Open	High	Low	Value	Volume
$14.75	$15.87	$13.94	$135.3M	9.018M

Buyers (Bids)

No.	Vol.	Price($)
3	533	$14.95

Sellers (Offers)

Price($)	Vol.	No.
$15.00	2224	3

View Market Depth

No.	Vol.	Price($)
3	533	14.950
1	401	14.940
4	634	14.930
1	320	14.920
15	16326	14.900

Price($)	Vol.	No.
15.000	2224	3
15.040	66	1
15.070	1540	2
15.080	14700	1
15.150	638	1

Last trade - 16.16pm 28/08/2025 (20 minute delay)


Last $14.96		Change -3.450 ( 18.6 %)
Open	High	Low	Volume
$14.69	$15.87	$13.95	1601021
Last updated 15.59pm 28/08/2025 ?

TLX (ASX) Chart

TELIX PHARMACEUTICALS LIMITED - Charts / Financials

Directors & Senior Management

Buyers (Bids)

Sellers (Offers)

Top Stories